EverImmune raises €5M to enter clinical phase in microbiome immuno-oncology
NovAliX signs partnership agreement to design and screen Sanofi’s new DNA-Encoded Libraries
Provepharm Life Solutions obtains FDA authorization to produce its active ingredients for the United States
Following GMP certification earned in 2019 for its new production unit, Provepharm now has full control over its production chain for Europe and the US
Robocath successfully performs first carotid stenting in France with R-ONE™ Robot at Rennes University Hospital
Caixa Capital Risc Leads sale of Sanifit Therapeutics to Vifor Pharma with upfront payment of €205M
• Largest acquisition in history of Spanish biotechnology sector and largest operation to date for Caixa Capital Risc
• Holding 20% of the capital, Caixa Capital Risc is Sanifit’s biggest stakeholder and has supported company since 2006, participating in all financing rounds for a total investment of over €23M
Deciphera obtient l’autorisation de la commission européenne pour le QINLOCK® (RIPRETINIB) en traitement de quatrième ligne des tumeurs stromales gastro-intestinales (GIST)
Robocath – Ongoing PR to Sustain market visibility
Ongoing PR to Sustain market visibility
Provepharm – Investment: New uses for well-known molecules
Investment: New uses for well-known molecule
Microlight 3D – Multi-lingual product launch
MULTI-LINGUAL PRODUCT LAUNCH